Eagle Pharmaceuticals Inc EGRX Balance Sheet

Income Statement

Quarter End	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	256.26M	253.73M	320.17M	381.76M	386.45M	406.16M	414.18M	404.82M
Total Current Assets	171.69M	172.61M	240.17M	194.46M	185.05M	188.75M	192.49M	187.25M
Cash and Equivalents	99.74M	97.66M	69.52M	36.56M	15.38M	55.32M	21.9M	15.35M
Total Non-Current Assets	86.34M	82.76M	81.63M	188.76M	202.7M	218.57M	222.8M	218.59M
Total Liabilities	70.97M	77.28M	104.21M	143.77M	154.67M	172.6M	171.33M	152.78M
Total Current Liabilities	48.43M	74.38M	101.64M	108.96M	121.83M	111.09M	97.81M	86.63M
Total Non-Current Liabilities	42.03M	2.9M	2.56M	62.83M	59.27M	117.73M	142.35M	128.05M
Common Equity	17k	17k	17k	18k	18k	18k	18k	18k
Retained Earnings	82.06M	75.86M	119.92M	110.47M	103.34M	111.5M	117.25M	122.42M

Year End December 30 2022	2015	2016	2017	2018	2019	2020	2021	2022
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	124.61M	214.32M	270.06M	238.6M	254.55M	253.19M	253.73M	406.16M
Total Current Assets	122.26M	109.11M	188.7M	163.84M	179.45M	166.07M	172.61M	188.75M
Cash and Equivalents	79.08M	52.82M	114.66M	78.79M	109.78M	103.16M	97.66M	55.32M
Total Non-Current Assets	90.34M	151.23M	179.14M	160.76M	179.17M	186.01M	176.45M	233.56M
Total Liabilities	34.26M	63.09M	90.92M	77.84M	75.38M	67.18M	77.28M	172.6M
Total Current Liabilities	34.26M	40.97M	47.3M	39.69M	38.82M	38.09M	74.38M	111.09M
Total Non-Current Liabilities	0	22.13M	86.52M	76.31M	70.11M	54.23M	2.9M	117.73M
Total Equity	90.34M	151.23M	179.14M	160.76M	179.17M	186.01M	176.45M	233.56M
Common Equity	15k	16k	16k	17k	17k	17k	17k	18k
Retained Earnings	-107.11M	-25.66M	26.28M	58.19M	72.5M	84.49M	75.86M	111.5M